Global Pharma Organization Implements Advanced Signals as Part of LifeSphere Safety Platform
BOSTON, April 10, 2025 /PRNewswire/ -- ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, today...
Pharmaceutical
Prezent Taps Janet Dorling to Join Board and Fuel the Next Wave of AI Innovation in Biopharma
The strategic appointment is set to accelerate Prezent's ambitious AI roadmap and boost its proprietary 3-in-1 AI presentation agent across...
EVERSANA Unveils EVERSANA ORCHESTRATE™ MLR, an AI-Powered Solution to Transform the Medical, Legal & Regulatory Process
Platform built in collaboration with Amazon Web Services, Modus Create to produce unmatched accuracy, efficiencies and compliance for life science...
Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains – Using Amber Waves of Grain
Ginkgo Bioworks and partners awarded $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines using wheat germ...
MedSpeed Celebrates 25 Years of Transforming Healthcare Logistics
ELMHURST, Ill., April 10, 2025 /PRNewswire/ -- MedSpeed, a leading provider of same-day logistics services to the health care industry,...
Qnovia, Inc. Announces Leadership Transition and Strategic Appointments to Support UK Commercialization Strategy
Mario Danek Appointed President and CEO; James Watson Joins as COO, Francesca Lanuza Appointed Director of Regulatory Affairs, and Dr....
Senti Bio Bolsters Scientific Advisory Board with Appointment of James B. Trager, Ph.D.
Industry leader in the development and application of cellular therapies, including CAR NK products, for cancer Led development of multiple...
Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21
WASHINGTON, April 10, 2025 (GLOBE NEWSWIRE) -- Geoff Dow, infectious disease product development expert and chief executive officer of 60...
Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency
Phenotypic Characterization of ENPP1 Deficiency JBMR image of the phenotypic characterization of ENPP1 Deficiency - Data from the largest retrospective...
Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program
NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 10, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit" or the...
Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder
Vancouver, Canada, April 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
Evaxion to present at World Vaccine Congress
Congress will take place April 21-24, 2025, in Washington, D.C.COPENHAGEN, Denmark, April 10, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX)...
Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema
DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME)Over...
Avalyn to Participate in Upcoming Investor Conference in April
CAMBRIDGE, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled...
Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors
Dr. Roger Dansey Dr. Roger Dansey joins Ottimo Pharma Limited Board of Directors Dansey, a former senior executive at Pfizer...
Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders
A$5.0 million commitment received from Australian-based private investorA$10.8 million Entitlement Offer at the same offer price as the placementFunds to...
BriaCell’s Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3
BriaPro is developing novel antibodies to B7-H3, a key cancer antigen and immune checkpointHighly expressed on the cell surfaces of...
Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2025
Highlights will include data from non-clinical and real-world patient useBOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a...
Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign
Episode Highlights a Truly Remarkable Patient Story Spanning 79 Years Video features 79-year-old Norma Coles, believed to be among the...
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced the presentation of data yesterday highlighting...